| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |